These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1036928)

  • 1. [Isolation and characterisation of two main metabolites of ifosfamide from human urine (author's transl)].
    Norpoth K; Müller G; Raidt H
    Arzneimittelforschung; 1976; 26(7):1376-7. PubMed ID: 1036928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantitative determination of cyclophosphamide, ifosfamide, and trofosfamide and their stable metabolites on TLC-plates with the aid of 4-pyridine-aldehyde-2-benzothiazolyl-hydrazone (PBH) (author's transl)].
    Norpoth K; Addicks HW; Witting U; Mŭller G; Raidt H
    Arzneimittelforschung; 1975 Sep; 25(9):1331-6. PubMed ID: 1242654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the metabolism of isopnosphamide (NSC-109724) in man.
    Norpoth K
    Cancer Treat Rep; 1976 Apr; 60(4):437-43. PubMed ID: 1277219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecific synthesis of chiral metabolites of ifosfamide and their determination in the urine.
    Misiura K; Okruszek A; Pankiewicz K; Stec WJ; Czownicki Z; Utracka B
    J Med Chem; 1983 May; 26(5):674-9. PubMed ID: 6842506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disaccharidases of the intestinal mucosa of the rat after cytostatic combined therapy with vincristin sulphate and ifosfamide (author's transl)].
    Hartwich G; Domschke W; Matzkies F
    Arzneimittelforschung; 1976; 26(3):350-2. PubMed ID: 989325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric characterization of activated N-(2-chloroethyl)amino oxazaphosphorine derivative.
    Przybylski M; Ringsdorf H; Lenssen U; Peter G; Voelcker G; Wagner T; Hohorst HJ
    Biomed Mass Spectrom; 1977 Aug; 4(4):209-15. PubMed ID: 912018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ifosfamide and the metabolites of side chain oxidation--excretion in urine in various pediatric therapeutic protocols].
    Boos J; Welslau U; Ritter J; Blaschke G; Schellong G
    Klin Padiatr; 1992; 204(4):299-305. PubMed ID: 1518269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.
    Gilard V; Martino R; Malet-Martino M; Niemeyer U; Pohl J
    J Med Chem; 1999 Jul; 42(14):2542-60. PubMed ID: 10411475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the urinary excretion of ifosfamide and its N-dechloroethylated metabolites in children using 31P-NMR spectroscopy.
    Misiura K; Zubowska M; Zielińska E
    Arzneimittelforschung; 2003; 53(5):372-7. PubMed ID: 12854365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of urinary 2- and 3-dechloroethylated metabolites of ifosfamide by high-performance liquid chromatography.
    Goren MP
    J Chromatogr; 1991 Oct; 570(2):351-9. PubMed ID: 1797850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children.
    Boddy AV; Yule SM; Wyllie R; Price L; Pearson AD; Idle JR
    Cancer Res; 1993 Aug; 53(16):3758-64. PubMed ID: 8339288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side chain oxidation of ifosfamide in man.
    Norpoth K; Raidt H; Witting U; Müller G; Norpoth R
    Klin Wochenschr; 1975 Nov; 53(22):1075-6. PubMed ID: 1226040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ifosfamide, 2- and 3-dechloroethylifosfamide in plasma and urine of cancer patients treated with a 10-day continuous infusion of ifosfamide.
    Kaijser GP; Keizer HJ; Beijnen JH; Bult A; Underberg WJ
    Anticancer Res; 1996; 16(5B):3247-57. PubMed ID: 8920799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion kinetics of ifosfamide side-chain metabolites in children on continuous and short-term infusion.
    Silies H; Blaschke G; Hohenlöchter B; Rossi R; Jürgens H; Boos J
    Int J Clin Pharmacol Ther; 1998 May; 36(5):246-52. PubMed ID: 9629987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of trofosfamide and its dechloroethylated metabolites.
    Hempel G; Krümpelmann S; May-Manke A; Hohenlöchter B; Blaschke G; Jürgens H; Boos J
    Cancer Chemother Pharmacol; 1997; 40(1):45-50. PubMed ID: 9137528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolism of enantiomers of the cytostatic ifosfamide].
    Blaschke G; Widey W
    Arzneimittelforschung; 1989 Feb; 39(2):223-6. PubMed ID: 2730691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].
    Teufel G; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):274-9. PubMed ID: 1261795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A search for new metabolites of N,N',N''-triethylenethiophosphoramide.
    van Maanen MJ; Tijhof IM; Damen JM; Versluis C; van den Bosch JJ; Heck AJ; Rodenhuis S; Beijnen JH
    Cancer Res; 1999 Sep; 59(18):4720-4. PubMed ID: 10493531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Solid phase-sample preparation of ifosfamide and chloroethyl metabolites in biological material. 1. Determination in plasma and urine].
    Hennig B; Rädler S; Blaschke G; Boos J
    Pharmazie; 1992 Oct; 47(10):783-7. PubMed ID: 1480658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatographic analysis of the enantiomers of ifosfamide and some of its metabolites in plasma and urine.
    Kaijser GP; Beijnen JH; Bult A; Keizer HJ; Underberg WJ
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):131-8. PubMed ID: 9106037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.